HOME > ARCHIVE

ARCHIVE

DIAGNOSTIC NEWS IN BRIEF

September 9, 2002
BULLETIN

September 9, 2002
< Advertisement >

September 9, 2002
10 Wholesalers Have 108 Returns of Damaged Goods in 1 Year

September 9, 2002
OTC NEWS IN BRIEF

September 9, 2002
Hiring of New Graduates by Wholesalers Remains at Low Level: PJ Survey

September 9, 2002
CORPORATE ROUNDUP NEWS IN BRIEF

September 9, 2002
AstraZeneca Hires Largest Number of New Graduates in 2002: PJ Survey

September 9, 2002
NEW PRODUCTS

September 9, 2002
MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF

September 9, 2002
BUSINESS NEWS IN BRIEF

September 9, 2002
REGULATORY NEWS IN BRIEF

September 9, 2002
Korosho Requests Tax Reform to Beef Up Industry

September 9, 2002
Korosho's FY2003 Budget Request Totals \19,523.7 Bil., Up 4.58%

September 9, 2002
Drug Industry Vision Finalized

September 9, 2002
Telmisartan, Brinzolamide Recommended for Approval

September 9, 2002
PAL Amendment Discussed: Jiho Seminar -2-

September 9, 2002
PAL Amendment Discussed: Jiho Seminar

September 9, 2002
Janssen's Virtual Hallucination System Used Widely

September 2, 2002
Human Tissue Transplantation GL Compiled by Society

September 2, 2002

ページ

Chuikyo Debate on FY2026 Drug Pricing Reform

Chuikyo OKs New CEA Handling, with Third-Party Verification Ahead

Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…

COMMENTARY

Shift Underway in Pharma Workforce as Sales Roles Shrink, Manufacturing Rises

By Hayate Horiguchi

Japan’s pharmaceutical industry is undergoing a structural shift in its workforce, with the role of sales reps shrinking while production…

COLUMN

The Patient North Star: How Gilead Japan Redefined Innovation

By Philip Carrigan

In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…